SCHEMBL16189591

SCHEMBL16189591

Cc1cc(-c2cccc(-c3cc(-c4nc(-c5ccccc5)cc(-c5ccccc5)n4)cc(-c4c5ccccc5cc5ccccc45)c3)c2)cc(C)n1

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.40
KMT2A Q03164 8/20 0.40
MAPT P10636 5/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 4/20 0.40
KDM4E B2RXH2 3/20 0.40
LMNA P02545 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NTSR1 P30989 1/20 0.39
GLA P06280 1/20 0.38
AGTR1 P30556 1/20 0.38
ADORA3 P0DMS8 1/20 0.36
ADORA1 P30542 4/20 0.36
ADORA2A P29274 3/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16189161 0.95 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189574 0.93 MEN1 (0.42) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189533 0.92 LMNA (0.43) MEN1KMT2AMAPTHPGDKDM4E
SCHEMBL17532839 0.90 LMNA (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189583 0.90 KMT2A (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189573 0.90 CYP3A4 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189570 0.88 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189339 0.88 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189148 0.88 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189160 0.86 WNT3A (0.41) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9780310-B2 Heterocyclic compound for organic electroluminescent device and its application TOSOH CORPORATION (JP) 2017-10-03 US disclosed
US-9780310-B2 Heterocyclic compound for organic electroluminescent device and its application TOSOH CORPORATION (JP) 2017-10-03 US disclosed
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION TOSOH CORPORATION (JP) 2016-02-25 US disclosed
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION TOSOH CORPORATION (JP) 2016-02-25 US disclosed
WO-2014171541-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE ELEMENT AND APPLICATION THEREFOR 東ソー株式会社 (JP) 2014-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160056388-A1 HETEROCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ITS APPLICATION AOC2, AZI2, KCNH2 MEN1 2195/4885KMT2A 1481/4885MAPT 4371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.